Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19

SARS-CoV-2 is a positive-sense RNA virus and it is the causative agent of the global COVID-19 outbreak. COVID-19 is similar to the previous outbreaks for instance SARS in 2002-2003 and MERS in 2012. As the peptides have many advantages, peptide-based therapeutics might be one of the possible ways in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Jagat Narayan, Guo, Guang-Qin, Krishnan, Anand, Ramesh, Muthusamy, Katari, Naresh Kumar, Shahbaaz, Mohd, Abdellattif, Magda H., Singh, Sachin Kumar, Dua, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022
Materias:
Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498005/
https://www.ncbi.nlm.nih.gov/pubmed/34689960
http://dx.doi.org/10.1016/j.therap.2021.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498005/
https://www.ncbi.nlm.nih.gov/pubmed/34689960
http://dx.doi.org/10.1016/j.therap.2021.09.007

Ejemplares similares